Shares of other companies:
April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
Amazon Web Services Expands Bedrock GenAI Service
April 23, 2024
Why Microsoft Stands Out As A Pre-Earnings Buy
April 23, 2024
Wall Street Lunch: Big Tech Bearishness?
April 22, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
ARDX Stock News and Mentions of Ardelyx, Inc. Stocktwits
Updated: April 24, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Ardelyx Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Ardelyx, Inc. (ARDX).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Ardelyx stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Ardelyx, Inc. (ARDX)
April 5, 2024 (13:07) / "Business Insider" (by Benzinga Insights)
A Closer Look at 6 Analyst Recommendations For Ardelyx
Analysts' ratings for Ardelyx ( NASDAQ:ARDX ) over the last quarter vary from bullish to bearish, as provided by 6 analysts. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
In Article Trend: Somewhat-Bullish
April 3, 2024 (15:30) / "Benzinga" (by Globe Newswire)
Robust Growth Expected In The Intestinal Pseudo Obstruction Treatment Market: Market To Grow At A Rate Of More Than 5% Through 2024-2028 As Per TBRC's Intestinal Pseudo Obstruction Treatment Global Market Report 2024
LONDON, April 03, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Intestinal Pseudo Obstruction Treatment Global Market Report 2024, the intestinal pseudo obstruction treatment market has witnessed strong growth in recent years, with the market size projected to increase from ...
In Article Trend: Neutral
March 29, 2024 (22:45) / "PR Newswire" (by Research and Markets)
Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment ... PR ...
In Article Trend: Somewhat-Bullish
March 12, 2024 (20:35) / "GlobeNewswire" (by Inc.)
Ardelyx, Inc. Reports Employment Inducement Grants
WALTHAM, Mass., March 12, 2024 ( GLOBE NEWSWIRE ) -- Ardelyx, Inc. ( Nasdaq: ARDX ) , a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on March 9, 2024, ...
In Article Trend: Somewhat-Bullish
March 12, 2024 (20:35) / "Benzinga" (by Globe Newswire)
Ardelyx, Inc. Reports Employment Inducement Grants - Ardelyx ( NASDAQ:ARDX )
WALTHAM, Mass., March 12, 2024 ( GLOBE NEWSWIRE ) -- Ardelyx, Inc.
In Article Trend: Somewhat-Bullish
February 27, 2024 (09:00) / "Stocknews.com" (by ABMN Staff)
Ardelyx ( NASDAQ:ARDX ) Downgraded by StockNews.com
StockNews.com downgraded shares of Ardelyx ( NASDAQ:ARDX - Free Report ) from a hold rating to a sell rating in a research note published on Monday morning. Other analysts have also recently issued research reports about the company.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website